Gene expression profiling in adrenocortical neoplasia

Molecular and Cellular Endocrinology

Volumn 351, Issue 1, 2012, Pages 111-117

  Assie, G ^a,b,c   Giordano, T J ^e   Bertherat, J ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Sorbonne Paris Cité ^*  (France)

^d Rare Adrenal Cancer Network COMETE INCA   (France)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Adrenocortical carcinoma; Diagnosis; Prognosis tumorigenesis; Transcriptome

Indexed keywords

ADRENAL CORTEX CARCINOMA; BECKWITH WIEDEMANN SYNDROME; BETA CATENIN GENE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PROGNOSIS; DISEASE ASSOCIATION; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC TRANSCRIPTION; H19 GENE; HUMAN; IG2 GENE; IGF2 GENE; KCNQ1 GENE; ONCOGENE; P57KIP2 GENE; PRIORITY JOURNAL; REVIEW; TP53 GENE; TRANSCRIPTOMICS; WNT GENE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADRENOCORTICAL CARCINOMA; ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS;

EID: 84857119460     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.09.044     Document Type: Review

References (42)

1. Almeida M.Q., Fragoso M.C.B.V., Lotfi C.F.P., Santos M.G., Nishi M.Y., Costa M.H.S., Lerario A.M., Maciel C.C., Mattos G.E., Jorge A.A.L., Mendonca B.B., Latronico A.C. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J. Clin. Endocrinol. Metab 2008, 93:3524-3531.
2. Assié G., Antoni G., Tissier F., Caillou B., Abiven G., Gicquel C., Leboulleux S., Travagli J.-P., Dromain C., Bertagna X., Bertherat J., Schlumberger M., Baudin E. Prognostic parameters of metastatic adrenocortical carcinoma. J. Clin. Endocrinol. Metab 2007, 92:148-154.
3. Assié, G., Raggazon, B., Reyniès, A. de, Carrasco, C., Guillot, M., Barreau, O., Rickmann, D., Tissier, F., Bertagna, X., Clauser, E., Bertherat, J., 2009. Characterization of Two Groups of Adrenocortical Carcinomas (ACCs) with Different Outcomes Revealed by Gene Profiling. Présenté à The Endocrine Society's 91st Annual Meeting, Washington DC.
4. Assié G., Guillaud-Bataille M., Ragazzon B., Bertagna X., Bertherat J., Clauser E. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses. Trends Endocrinol. Metab. 2010, 21:325-334.
5. Barlaskar F.M., Spalding A.C., Heaton J.H., Kuick R., Kim A.C., Thomas D.G., Giordano T.J., Ben-Josef E., Hammer G.D. Preclinical targeting of the Type 1 Insulin-like growth factor receptor in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2008, 78:90-99.
6. Barzon L., Chilosi M., Fallo F., Martignoni G., Montagna L., Palu G., Boscaro M. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur. J. Endocrinol. 2001, 145:207-212.
7. de Fraipont F., El Atifi M., Cherradi N., Le Moigne G., Defaye G., Houlgatte R., Bertherat J., Bertagna X., Plouin P.-F., Baudin E., Berger F., Gicquel C., Chabre O., Feige J.-J. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J. Clin. Endocrinol. Metab. 2005, 90:1819-1829.
8. de Reyniès A., Assié G., Rickman D.S., Tissier F., Groussin L., Rene-Corail F., Dousset B., Bertagna X., Clauser E., Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 2009, 8:90-99.
9. Fernandez-Ranvier G.G., Weng J., Yeh R.-F., Khanafshar E., Suh I., Barker C., Duh Q.Y., Clark O.H., Kebebew E. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch. Surg. 2008, 143:841-846. discussion 846.
10. Fernandez-Ranvier G.G., Weng J., Yeh R.-F., Shibru D., Khafnashar E., Chung K.-W., Hwang J., Duh Q.Y., Clark O.H., Kebebew E. Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13. World J. Surg. 2008, 32:873-881.
11. Gaujoux S., Pinson S., Gimenez-Roqueplo A.-P., Amar L., Ragazzon B., Launay P., Meatchi T., Libé R., Bertagna X., Audebourg A., Zucman-Rossi J., Tissier F., Bertherat J. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clin. Cancer Res. 2010, 16:5133-5141.
12. Gicquel C., Le Bouc Y. Hormonal regulation of fetal growth. Horm. Res. 2006, 65(Suppl. 3):28-33.
13. Gicquel C., Bertagna X., Schneid H., Francillard-Leblond M., Luton J.P., Girard F., Le Bouc Y. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 1994, 78:1444-1453.
14. Gicquel C., Bertagna X., Gaston V., Coste J., Louvel A., Baudin E., Bertherat J., Chapuis Y., Duclos J.M., Schlumberger M., Plouin P.F., Luton J.P., Le Bouc Y. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001, 61:6762-6767.
15. Giordano T.J., Thomas D.G., Kuick R., Lizyness M., Misek D.E., Smith A.L., Sanders D., Aljundi R.T., Gauger P.G., Thompson N.W., Taylor J.M.G., Hanash S.M. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003, 162:521-531.
16. Giordano T.J., Kuick R., Else T., Gauger P.G., Vinco M., Bauersfeld J., Sanders D., Thomas D.G., Doherty G., Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 2009, 15:668-676.
17. Hallegger M., Llorian M., Smith C.W.J. Alternative splicing: global insights. FEBS J. 2010, 277:856-866.
18. Huang H., He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell Biol. 2008, 20:119-125.
19. Kaufmann M., Pusztai L. Use of standard markers and incorporation of molecular markers into breast cancer therapy: consensus recommendations from an International Expert Panel. Cancer 2011, 117:1575-1582.
20. Keegan C.E., Hammer G.D. Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol. Metab. 2002, 13:200-208.
21. Laurell C., Velázquez-Fernández D., Lindsten K., Juhlin C., Enberg U., Geli J., Höög A., Kjellman M., Lundeberg J., Hamberger B., Larsson C., Nilsson P., Bäckdahl M. Transcriptional profiling enables molecular classification of adrenocortical tumours. Eur. J. Endocrinol. 2009, 161:141-152.
22. Libé R., Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur. J. Endocrinol. 2005, 153:477-487.
23. Libè R., Groussin L., Tissier F., Elie C., René-Corail F., Fratticci A., Jullian E., Beck-Peccoz P., Bertagna X., Gicquel C., Bertherat J. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Clin. Cancer Res. 2007, 13:844-850.
24. Lombardi C.P., Raffaelli M., Pani G., Maffione A., Princi P., Traini E., Galeotti T., Rossi E.D., Fadda G., Bellantone R. Gene expression profiling of adrenal cortical tumors by cDNA macroarray analysis. Results of a preliminary study. Biomed. Pharmacother. 2006, 60:186-190.
25. Quackenbush J. Microarray analysis and tumor classification. N. Engl. J. Med. 2006, 354:2463-2472.
26. Ragazzon B., Libé R., Gaujoux S., Assié G., Fratticci A., Launay P., Clauser E., Bertagna X., Tissier F., de Reyniès A., Bertherat J. Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. Cancer Res. 2010, 70:8276-8281.
27. Ragazzon B., Assié G., Bertherat J. Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments. Endocr. Relat. Cancer 2011, 18. R15-27.
28. Reincke M., Karl M., Travis W.H., Mastorakos G., Allolio B., Linehan H.M., Chrousos G.P. P53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J. Clin. Endocrinol. Metab. 1994, 78:790-794.
29. Ribeiro R.C., Sandrini F., Figueiredo B., Zambetti G.P., Michalkiewicz E., Lafferty A.R., DeLacerda L., Rabin M., Cadwell C., Sampaio G., Cat I., Stratakis C.A., Sandrini R. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. USA 2001, 98:9330-9335.
30. Seki M., Tanaka K., Kikuchi-Yanoshita R., Konishi M., Fukunari H., Iwama T., Miyaki M. Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis. Hum. Genet. 1992, 89:298-300.
31. Slater E.P., Diehl S.M., Langer P., Samans B., Ramaswamy A., Zielke A., Bartsch D.K. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur. J. Endocrinol. 2006, 154:587-598.
32. Soon P.S.H., Libe R., Benn D.E., Gill A., Shaw J., Sywak M.S., Groussin L., Bertagna X., Gicquel C., Bertherat J., McDonald K.L., Sidhu S.B., Robinson B.G. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Ann. Surg. 2008, 247:157-164.
33. Soon P.S.H., Gill A.J., Benn D.E., Clarkson A., Robinson B.G., McDonald K.L., Sidhu S.B. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocr. Relat. Cancer 2009, 16:573-583.
34. Szabó P.M., Tamási V., Molnár V., Andrásfalvy M., Tömböl Z., Farkas R., Kövesdi K., Patócs A., Tóth M., Szalai C., Falus A., Rácz K., Igaz P. Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed. Oncogene 2010, 29:3163-3172.
35. Tissier F., Cavard C., Groussin L., Perlemoine K., Fumey G., Hagneré A.-M., Rene-Corail F., Jullian E., Gicquel C., Bertagna X., Vacher-Lavenu M.-C., Perret C., Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer. Res. 2005, 65:7622-7627.
36. Tömböl Z., Szabó P.M., Molnár V., Wiener Z., Tölgyesi G., Horányi J., Riesz P., Reismann P., Patócs A., Likó I., Gaillard R.-C., Falus A., Rácz K., Igaz P. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr. Relat. Cancer 2009, 16:895-906.
37. Velázquez-Fernández D., Laurell C., Geli J., Höög A., Odeberg J., Kjellman M., Lundeberg J., Hamberger B., Nilsson P., Bäckdahl M. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 2005, 138:1087-1094.
38. Weiss L.M. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 1984, 8:163-169.
39. Weiss L.M., Medeiros L.J., Vickery A.L. Pathologic features of prognostic significance in adrenocortical carcinoma. Am. J. Surg. Pathol. 1989, 13:202-206.
40. Weksberg, R., Smith, A.C., Squire, J., Sadowski, P., 2003. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum. Mol. Genet 12 Spec No 1, R61-8.
41. West A.N., Neale G.A., Pounds S., Figueredo B.C., Rodriguez Galindo C., Pianovski M.A.D., Oliveira Filho A.G., Malkin D., Lalli E., Ribeiro R., Zambetti G.P. Gene expression profiling of childhood adrenocortical tumors. Cancer Res. 2007, 67:600-608.
42. Xu J.-Z., Wong C.-W. Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments. Cancer Lett. 2010, 296:9-16.